Nasal Covid-19 Vaccine

Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022
Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022Swarajya StaffSep 7, 2021 06:01 PM +05:30 IST
Intranasal Covid Vaccines: How They Can Help Fight The Pandemic 
Intranasal Covid Vaccines: How They Can Help Fight The Pandemic Bhaswati Guha Majumder May 4, 2021 01:25 PM +05:30 IST
Phase 1 Trials Of Bharat Biotech's Nasal Vaccine For Covid-19 Now Underway: MD Dr Krishna Ella
Phase 1 Trials Of Bharat Biotech's Nasal Vaccine For Covid-19 Now Underway: MD Dr Krishna EllaSwarajya StaffApr 25, 2021 12:31 PM +05:30 IST
Load More